Long intergenic non-coding RNA HOTAIRM1 regulates cell cycle progression during myeloid maturation in NB4 human promyelocytic leukemia cells

RNA Biology

Volumn 11, Issue 6, 2014, Pages

  Zhang, Xueqing ^a   Weissman, Sherman M ^b   Newburger, Peter E ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cell cycle; Gene expression; Granulocyte; HOX cluster; Integrin; Long noncoding RNA; Myeloid; Myelopoiesis

Indexed keywords

ALPHA4 INTEGRIN; GLYCOPROTEIN P 15095; PROTEIN HOTAIRM1; RETINOIC ACID; RNA; UNCLASSIFIED DRUG; UNTRANSLATED RNA; HOTAIR LONG UNTRANSLATED RNA, HUMAN; LONG UNTRANSLATED RNA;

ARTICLE; BONE MARROW CELL; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL MATURATION; CELL SURFACE; DNA REPLICATION; GENE CONTROL; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; LEUKEMIA CELL; LEUKOCYTE ACTIVATION; PHASE TRANSITION; PROMYELOCYTIC LEUKEMIA; CELL CYCLE; CELL CYCLE CHECKPOINT; CELL DIFFERENTIATION; CELL PROLIFERATION; CLUSTER ANALYSIS; DRUG EFFECTS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE SILENCING; GENETICS; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

ANTIGENS, CD11C; CELL CYCLE; CELL CYCLE CHECKPOINTS; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL PROLIFERATION; CLUSTER ANALYSIS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, LEUKEMIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; INTEGRIN ALPHA4; LEUKEMIA, PROMYELOCYTIC, ACUTE; RNA, LONG NONCODING; TRETINOIN;

EID: 84906351069     PISSN: 15476286     EISSN: 15558584     Source Type: Journal    
DOI: 10.4161/rna.28828     Document Type: Article

References (82)

1. Gibcus JH, Dekker J. The context of gene expression regulation. F1000 Biol Rep 2012; 4:8; PMID:22500194; http://dx.doi.org/10.3410/B4-8
2. Spizzo R, Almeida MI, Colombatti A, Calin GA. Long non-coding RNAs and cancer: a new frontier of translational research? Oncogene 2012; 31:4577-87; PMID:22266873; http://dx.doi.org/10.1038/onc.2011.621
3. Wapinski O, Chang HY. Long noncoding RNAs and human disease. Trends Cell Biol 2011; 21:354-61; PMID:21550244; http://dx.doi.org/10.1016/j.tcb.2011.04.001
4. Ruddle FH, Bartels JL, Bentley KL, Kappen C, Murtha MT, Pendleton JW. Evolution of Hox genes. Annu Rev Genet 1994; 28:423-42; PMID:7893134; http://dx.doi.org/10.1146/annurev.ge.28.120194.002231
5. Deschamps J. Ancestral and recently recruited global control of the Hox genes in development. Curr Opin Genet Dev 2007; 17:422-7; PMID:17870464; http://dx.doi.org/10.1016/j.gde.2007.07.008
6. Wellik DM. Hox genes and vertebrate axial pattern. Curr Top Dev Biol 2009; 88:257-78; PMID:19651308; http://dx.doi.org/10.1016/S0070-2153(09)88009-5
7. Ruddle FH, Bartels JL, Bentley KL, Kappen C, Murtha MT, Pendleton JW. Evolution of Hox genes. Annu Rev Genet 1994; 28:423-42; PMID:7893134; http://dx.doi.org/10.1146/annurev.ge.28.120194.002231
8. Fuller JF, McAdara J, Yaron Y, Sakaguchi M, Fraser JK, Gasson JC. Characterization of HOX gene expression during myelopoiesis: role of HOX A5 in lineage commitment and maturation. Blood 1999; 93:3391-400; PMID:10233891
9. Iacovino M, Hernandez C, Xu Z, Bajwa G, Prather M, Kyba M. A conserved role for Hox paralog group 4 in regulation of hematopoietic progenitors. Stem Cells Dev 2009; 18:783-92; PMID:18808325; http://dx.doi.org/10.1089/scd.2008. 0227
10. Magnusson M, Brun ACM, Miyake N, Larsson J, Ehinger M, Bjornsson JM, Wutz A, Sigvardsson M, Karlsson S. HOXA10 is a critical regulator for hematopoietic stem cells and erythroid/megakaryocyte development. Blood 2007; 109:3687-96; PMID:17234739; http://dx.doi.org/10.1182/blood-2006-10-054676
11. Bei L, Lu Y, Bellis SL, Zhou W, Horvath E, Eklund EA. Identification of a HoxA10 activation domain necessary for transcription of the gene encoding beta3 integrin during myeloid differentiation. J Biol Chem 2007; 282:16846-59; PMID:17439948; http://dx.doi.org/10.1074/jbc.M609744200
12. Eklund E. The role of Hox proteins in leukemogenesis: insights into key regulatory events in hematopoiesis. Crit Rev Oncog 2011; 16:65-76; PMID:22150308; http://dx.doi.org/10.1615/CritRevOncog.v16.i1-2.70
13. Lindsey S, Huang W, Wang H, Horvath E, Zhu C, Eklund EA. Activation of SHP2 protein-tyrosine phosphatase increases HoxA10-induced repression of the genes encoding gp91(PHOX) and p67(PHOX). J Biol Chem 2007; 282:2237-49; PMID:17138561; http://dx.doi.org/10.1074/jbc.M608642200
14. Argiropoulos B, Humphries RK. Hox genes in hematopoiesis and leukemogenesis. Oncogene 2007; 26:6766-76; PMID:17934484; http://dx.doi.org/10. 1038/sj.onc.1210760
15. Krivtsov AV, Twomey D, Feng Z, Stubbs MC, Wang Y, Faber J, Levine JE, Wang J, Hahn WC, Gilliland DG, et al. Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9. Nature 2006; 442:818-22; PMID:16862118; http://dx.doi.org/10.1038/nature04980
16. Zhang X, Lian Z, Padden C, Gerstein MB, Rozowsky J, Snyder M, Gingeras TR, Kapranov P, Weissman SM, Newburger PE. A myelopoiesis-associated regulatory intergenic noncoding RNA transcript within the human HOXA cluster. Blood 2009; 113:2526-34; PMID:19144990; http://dx.doi.org/10.1182/blood-2008-06-162164
17. Rinn JL, Kertesz M, Wang JK, Squazzo SL, Xu X, Brugmann SA, Goodnough LH, Helms JA, Farnham PJ, Segal E, et al. Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell 2007; 129:1311-23; PMID:17604720; http://dx.doi.org/10.1016/j.cell.2007.05.022
18. Birney E, Stamatoyannopoulos JA, Dutta A, Guigó R, Gingeras TR, Margulies EH, Weng Z, Snyder M, Dermitzakis ET, Thurman RE, et al.; ENCODE Project Consortium; NISC Comparative Sequencing Program; Baylor College of Medicine Human Genome Sequencing Center; Washington University Genome Sequencing Center; Broad Institute; Children's Hospital Oakland Research Institute. Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature 2007; 447:799-816; PMID:17571346; http://dx.doi.org/10.1038/nature05874
19. Mainguy G, Koster J, Woltering J, Jansen H, Durston A. Extensive polycistronism and antisense transcription in the mammalian Hox clusters. PLoS One 2007; 2:e356; PMID:17406680; http://dx.doi.org/10.1371/journal.pone.0000356
20. Wang KC, Chang HY. Molecular mechanisms of long noncoding RNAs. Mol Cell 2011; 43:904-14; PMID:21925379; http://dx.doi.org/10.1016/j.molcel.2011.08.018
21. Wang KC, Yang YW, Liu B, Sanyal A, Corces-Zimmerman R, Chen Y, Lajoie BR, Protacio A, Flynn RA, Gupta RA, et al. A long noncoding RNA maintains active chromatin to coordinate homeotic gene expression. Nature 2011; 472:120-4; PMID:21423168; http://dx.doi.org/10.1038/nature09819
22. Bertani S, Sauer S, Bolotin E, Sauer F. The noncoding RNA Mistral activates Hoxa6 and Hoxa7 expression and stem cell differentiation by recruiting MLL1 to chromatin. Mol Cell 2011; 43:1040-6; PMID:21925392; http://dx.doi.org/10.1016/j.molcel.2011.08.019
23. Wei W, Pelechano V, Järvelin AI, Steinmetz LM. Functional consequences of bidirectional promoters. Trends Genet 2011; 27:267-76; PMID:21601935; http://dx.doi.org/10.1016/j.tig.2011.04.002
24. Deaton AM, Webb S, Kerr ARW, Illingworth RS, Guy J, Andrews R, Bird A. Cell type-specific DNA methylation at intragenic CpG islands in the immune system. Genome Res 2011; 21:1074-86; PMID:21628449; http://dx.doi.org/10.1101/ gr.118703.110
25. Thomson JP, Skene PJ, Selfridge J, Clouaire T, Guy J, Webb S, Kerr ARW, Deaton A, Andrews R, James KD, et al. CpG islands influence chromatin structure via the CpG-binding protein Cfp1. Nature 2010; 464:1082-6; PMID:20393567; http://dx.doi.org/10.1038/nature08924
26. Illingworth R, Kerr A, Desousa D, Jørgensen H, Ellis P, Stalker J, Jackson D, Clee C, Plumb R, Rogers J, et al. A novel CpG island set identifies tissue-specific methylation at developmental gene loci. PLoS Biol 2008; 6:e22; PMID:18232738; http://dx.doi.org/10.1371/journal.pbio.0060022
27. Rozenberg JM, Shlyakhtenko A, Glass K, Rishi V, Myakishev MV, FitzGerald PC, Vinson C. All and only CpG containing sequences are enriched in promoters abundantly bound by RNA polymerase II in multiple tissues. BMC Genomics 2008; 9:67; PMID:18252004; http://dx.doi.org/10.1186/1471-2164-9-67
28. Lanotte M, Martin-Thouvenin V, Najman S, Balerini P, Valensi F, Berger R. NB4, a maturation inducible cell line with t(15;17) marker isolated from a human acute promyelocytic leukemia (M3). Blood 1991; 77:1080-6; PMID:1995093
29. Dimberg A, Oberg F. Retinoic acid-induced cell cycle arrest of human myeloid cell lines. Leuk Lymphoma 2003; 44:1641-50; PMID:14692514; http://dx.doi.org/10.1080/1042819031000083316
30. Hattori H, Zhang X, Jia Y, Subramanian KK, Jo H, Loison F, Newburger PE, Luo HR. RNAi screen identifies UBE2D3 as a mediator of all-trans retinoic acid-induced cell growth arrest in human acute promyelocytic NB4 cells. Blood 2007; 110:640-50; PMID:17420285; http://dx.doi.org/10.1182/blood-2006-11-059048
31. Gautier L, Cope L, Bolstad BM, Irizarry RA. affy - analysis of Affymetrix GeneChip data at the probe level. Bioinformatics 2004; 20:307-15; PMID:14960456; http://dx.doi.org/10.1093/bioinformatics/btg405
32. McCarthy DJ, Smyth GK. Testing significance relative to a fold-change threshold is a TREAT. Bioinformatics 2009; 25:765-71; PMID:19176553; http://dx.doi.org/10.1093/bioinformatics/btp053
33. Smyth GK. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 2004; 3:e3; PMID:16646809; http://dx.doi.org/10.2202/1544-6115.1027
34. Huang W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009; 4:44-57; PMID:19131956; http://dx.doi.org/10.1038/nprot.2008.211
35. Darzynkiewicz Z, Juan G. DNA content measurement for DNA ploidy and cell cycle analysis. Curr Protoc Cytom 2001; Chapter 7:Unit 7.5.
36. Payton JE, Grieselhuber NR, Chang LW, Murakami M, Geiss GK, Link DC, Nagarajan R, Watson MA, Ley TJ. High throughput digital quantification of mRNA abundance in primary human acute myeloid leukemia samples. J Clin Invest 2009; 119:1714-26; PMID:19451695; http://dx.doi.org/10.1172/JCI38248
37. Dimberg A, Bahram F, Karlberg I, Larsson L-G, Nilsson K, Oberg F. Retinoic acid-induced cell cycle arrest of human myeloid cell lines is associated with sequential down-regulation of c-Myc and cyclin E and posttranscriptional up-regulation of p27(Kip1). Blood 2002; 99:2199-206; PMID:11877298; http://dx.doi.org/10.1182/blood.V99.6.2199
38. Mollinedo F, López-Pérez R, Gajate C. Differential gene expression patterns coupled to commitment and acquisition of phenotypic hallmarks during neutrophil differentiation of human leukaemia HL-60 cells. Gene 2008; 419:16-26; PMID:18547747; http://dx.doi.org/10.1016/j.gene.2008.04.015
39. Theilgaard-Mönch K, Jacobsen LC, Borup R, Rasmussen T, Bjerregaard MD, Nielsen FC, Cowland JB, Borregaard N. The transcriptional program of terminal granulocytic differentiation. Blood 2005; 105:1785-96; PMID:15514007; http://dx.doi.org/10.1182/blood-2004-08-3346
40. Luo L, Uerlings Y, Happel N, Asli NS, Knoetgen H, Kessel M. Regulation of geminin functions by cell cycle-dependent nuclear-cytoplasmic shuttling. Mol Cell Biol 2007; 27:4737-44; PMID:17470552; http://dx.doi.org/10.1128/MCB.00123- 07
41. Bermudez VP, Farina A, Tappin I, Hurwitz J. Influence of the human cohesion establishment factor Ctf4/AND-1 on DNA replication. J Biol Chem 2010; 285:9493-505; PMID:20089864; http://dx.doi.org/10.1074/jbc.M109.093609
42. Abedin MJ, Kashio Y, Seki M, Nakamura K, Hirashima M. Potential roles of galectins in myeloid differentiation into three different lineages. J Leukoc Biol 2003; 73:650-6; PMID:12714580; http:// dx.doi.org/10.1189/jlb.0402163
43. Bellón T, López-Rodríguez C, Rubio MA, Jochems G, Bernabeu C, Corbi AL. Regulated expression of p150,95 (CD11c/CD18; alpha X/beta 2) and VLA-4 (CD49d/CD29; alpha 4/beta 1) integrins during myeloid cell differentiation. Eur J Immunol 1994; 24:41-7; PMID:8020569; http://dx.doi.org/ 10.1002/eji.1830240107
44. Barber N, Belov L, Christopherson RI. All-trans retinoic acid induces different immunophenotypic changes on human HL60 and NB4 myeloid leukaemias. Leuk Res 2008; 32:315-22; PMID:17561254; http://dx.doi.org/10.1016/j.leukres. 2007.04.013
45. Yassin ER, Abdul-Nabi AM, Takeda A, Yaseen NR. Effects of the NUP98-DDX10 oncogene on primary human CD34+ cells: role of a conserved helicase motif. Leukemia 2010; 24:1001-11; PMID:20339440; http://dx.doi.org/10.1038/leu.2010.42
46. Kutok JL, Yang X, Folkerth R, Adra CN. Characterization of the expression of HTm4 (MS4A3), a cell cycle regulator, in human peripheral blood cells and normal and malignant tissues. J Cell Mol Med 2011; 15:86-93; PMID:19818099; http:// dx.doi.org/10.1111/j.1582-4934.2009.00925.x
47. Mazurek A, Luo W, Krasnitz A, Hicks J, Powers RS, Stillman B. DDX5 regulates DNA replication and is required for cell proliferation in a subset of breast cancer cells. Cancer Discov 2012; 2:812-25; PMID:22750847; http://dx.doi.org/10.1158/2159-8290.CD-12-0116
48. Pulikkan JA, Peramangalam PS, Dengler V, Ho PA, Preudhomme C, Meshinchi S, Christopeit M, Nibourel O, Müller-Tidow C, Bohlander SK, et al. C/EBP α regulated microRNA-34a targets E2F3 during granulopoiesis and is down-regulated in AML with CEBPA mutations. Blood 2010; 116:5638-49; PMID:20889924; http://dx.doi.org/10.1182/blood-2010-04-281600
49. Im J-S, Ki S-H, Farina A, Jung D-S, Hurwitz J, Lee J-K. Assembly of the Cdc45-Mcm2-7-GINS complex in human cells requires the Ctf4/And-1, RecQL4, and Mcm10 proteins. Proc Natl Acad Sci U S A 2009; 106:15628-32; PMID:19805216; http://dx.doi.org/10.1073/pnas.0908039106
50. Yoshizawa-Sugata N, Masai H. Roles of human AND-1 in chromosome transactions in S phase. J Biol Chem 2009; 284:20718-28; PMID:19439411; http://dx.doi.org/10.1074/jbc.M806711200
51. Sherman MH, Bassing CH, Teitell MA. Regulation of cell differentiation by the DNA damage response. Trends Cell Biol 2011; 21:312-9; PMID:21354798; http://dx.doi.org/10.1016/j.tcb.2011.01.004
52. Salsi V, Ferrari S, Ferraresi R, Cossarizza A, Grande A, Zappavigna V. HOXD13 binds DNA replication origins to promote origin licensing and is inhibited by geminin. Mol Cell Biol 2009; 29:5775-88; PMID:19703996; http://dx.doi.org/10.1128/MCB.00509-09
53. Yamochi T, Kitabayashi A, Hirokawa M, Miura AB, Onizuka T, Mori S, Moriyama M. Regulation of BCL-6 gene expression in human myeloid/monocytoid leukemic cells. Leukemia 1997; 11:694-700; PMID:9180294; http://dx.doi.org/10. 1038/sj.leu.2400631
54. Barish GD, Yu RT, Karunasiri M, Ocampo CB, Dixon J, Benner C, Dent AL, Tangirala RK, Evans RM. Bcl-6 and NF-kappaB cistromes mediate opposing regulation of the innate immune response. Genes Dev 2010; 24:2760-5; PMID:21106671; http://dx.doi.org/10.1101/gad.1998010
55. Yu RY-L, Wang X, Pixley FJ, Yu JJ, Dent AL, Broxmeyer HE, Stanley ER, Ye BH. BCL-6 negatively regulates macrophage proliferation by suppressing autocrine IL-6 production. Blood 2005; 105:1777-84; PMID:15507530; http://dx.doi.org/10. 1182/blood-2004-08-3171
56. Nazari-Jahantigh M, Wei Y, Noels H, Akhtar S, Zhou Z, Koenen RR, Heyll K, Gremse F, Kiessling F, Grommes J, et al. MicroRNA-155 promotes atherosclerosis by repressing Bcl6 in macrophages. J Clin Invest 2012; 122:4190-202; PMID:23041630; http://dx.doi.org/10.1172/JCI61716
57. Schroeder MA, DiPersio JF. Mobilization of hematopoietic stem and leukemia cells. J Leukoc Biol 2012; 91:47-57; PMID:22028335; http://dx.doi.org/10.1189/jlb.0210085
58. Seoh JY. VLA-4 expression and cell cycling status during ex vivo expansion of human cord blood CD34+ cells. Acta Haematol 2001; 105:111-5; PMID:11408717; http://dx.doi.org/10.1159/000046547
59. Priestley GV, Scott LM, Ulyanova T, Papayannopoulou T. Lack of alpha4 integrin expression in stem cells restricts competitive function and self-renewal activity. Blood 2006; 107:2959-67; PMID:16357327; http://dx.doi.org/10.1182/blood-2005-07-2670
60. Brachtl G, Sahakyan K, Denk U, Girbl T, Alinger B, Hofbauer SW, Neureiter D, Hofbauer JP, Egle A, Greil R, et al. Differential bone marrow homing capacity of VLA-4 and CD38 high expressing chronic lymphocytic leukemia cells. PLoS One 2011; 6:e23758; PMID:21876768; http://dx.doi.org/10.1371/journal.pone. 0023758
61. D'Alo' F, Johansen LM, Nelson EA, Radomska HS, Evans EK, Zhang P, Nerlov C, Tenen DG. The amino terminal and E2F interaction domains are critical for C/EBP alpha-mediated induction of granulopoietic development of hematopoietic cells. Blood 2003; 102:3163-71; PMID:12869508; http://dx.doi.org/10.1182/blood- 2003-02-0479
62. Porse BT, Bryder D, Theilgaard-Mönch K, Hasemann MS, Anderson K, Damgaard I, Jacobsen SEW, Nerlov C. Loss of C/EBP alpha cell cycle control increases myeloid progenitor proliferation and transforms the neutrophil granulocyte lineage. J Exp Med 2005; 202:85-96; PMID:15983063; http://dx.doi.org/10.1084/jem.20050067
63. Pulikkan JA, Dengler V, Peramangalam PS, Peer Zada AA, Müller-Tidow C, Bohlander SK, Tenen DG, Behre G. Cell-cycle regulator E2F1 and microRNA-223 comprise an autoregulatory negative feedback loop in acute myeloid leukemia. Blood 2010; 115:1768-78; PMID:20029046; http://dx.doi.org/10.1182/blood-2009-08- 240101
64. Fatica A, Rosa A, Ballarino M, De Marchis ML, Rasmussen KD, Bozzoni I. Role of microRNAs in myeloid differentiation. Biochem Soc Trans 2008; 36:1201-5; PMID:19021525; http://dx.doi.org/10.1042/BST0361201
65. Hung T, Wang Y, Lin MF, Koegel AK, Kotake Y, Grant GD, Horlings HM, Shah N, Umbricht C, Wang P, et al. Extensive and coordinated transcription of noncoding RNAs within cell-cycle promoters. Nat Genet 2011; 43:621-9; PMID:21642992; http://dx.doi.org/10.1038/ng.848
66. Kretz M, Webster DE, Flockhart RJ, Lee CS, Zehnder A, Lopez-Pajares V, Qu K, Zheng GXY, Chow J, Kim GE, et al. Suppression of progenitor differentiation requires the long noncoding RNA ANCR. Genes Dev 2012; 26:338-43; PMID:22302877; http://dx.doi.org/10.1101/gad.182121.111
67. Miles J, Mitchell JA, Chakalova L, Goyenechea B, Osborne CS, O'Neill L, Tanimoto K, Engel JD, Fraser P. Intergenic transcription, cell-cycle and the developmentally regulated epigenetic profile of the human beta-globin locus. PLoS One 2007; 2:e630; PMID:17637845; http://dx.doi.org/10.1371/journal.pone. 0000630
68. Ginger MR, Shore AN, Contreras A, Rijnkels M, Miller J, Gonzalez-Rimbau MF, Rosen JM. A noncoding RNA is a potential marker of cell fate during mammary gland development. Proc Natl Acad Sci U S A 2006; 103:5781-6; PMID:16574773; http://dx.doi.org/10.1073/pnas.0600745103
69. Meighan CM, Schwarzbauer JE. Temporal and spatial regulation of integrins during development. Curr Opin Cell Biol 2008; 20:520-4; PMID:18603422; http://dx.doi.org/10.1016/j.ceb.2008.05.010
70. Liu J, DeYoung SM, Zhang M, Zhang M, Cheng A, Saltiel AR. Changes in integrin expression during adipocyte differentiation. Cell Metab 2005; 2:165-77; PMID:16154099; http://dx.doi.org/10.1016/j.cmet.2005.08.006
71. Miotto B, Graba Y. Control of DNA replication: a new facet of Hox proteins? Bioessays 2010; 32:800-7; PMID:20730947; http://dx.doi.org/10.1002/ bies.201000048
72. Lu Z, Hardt J, Kim JJ. Global analysis of genes regulated by HOXA10 in decidualization reveals a role in cell proliferation. Mol Hum Reprod 2008; 14:357-66; PMID:18456676; http://dx.doi.org/10.1093/molehr/gan023
73. Luo L, Yang X, Takihara Y, Knoetgen H, Kessel M. The cell-cycle regulator geminin inhibits Hox function through direct and polycomb-mediated interactions. Nature 2004; 427:749-53; PMID:14973489; http://dx.doi.org/10.1038/ nature02305
74. Bracken AP, Ciro M, Cocito A, Helin K. E2F target genes: unraveling the biology. Trends Biochem Sci 2004; 29:409-17; PMID:15362224; http://dx.doi.org/ 10.1016/j.tibs.2004.06.006
75. Dupuy AG, Caron E. Integrin-dependent phagocytosis: spreading from microadhesion to new concepts. J Cell Sci 2008; 121:1773-83; PMID:18492791; http://dx.doi.org/10.1242/jcs.018036
76. Cillo C, Cantile M, Mortarini R, Barba P, Parmiani G, Anichini A. Differential patterns of HOX gene expression are associated with specific integrin and ICAM profiles in clonal populations isolated from a single human melanoma metastasis. Int J Cancer 1996; 66:692-7; PMID:8647634; http://dx.doi.org/10.1002/(SICI)1097-0215(19960529)66:5〈692:: AID-IJC18〉3.0.CO;2-6
77. Boudreau NJ, Varner JA. The homeobox transcription factor Hox D3 promotes integrin alpha5beta1 expression and function during angiogenesis. J Biol Chem 2004; 279:4862-8; PMID:14610084; http://dx.doi.org/10.1074/jbc.M305190200
78. Streuli CH. Integrins and cell-fate determination. J Cell Sci 2009; 122:171-7; PMID:19118209; http://dx.doi.org/10.1242/jcs.018945
79. Jeanes AI, Wang P, Moreno-Layseca P, Paul N, Cheung J, Tsang R, Akhtar N, Foster FM, Brennan K, Streuli CH. Specific β-containing integrins exert differential control on proliferation and twodimensional collective cell migration in mammary epithelial cells. J Biol Chem 2012; 287:24103-12; PMID:22511753; http://dx.doi.org/10.1074/jbc.M112.360834
80. Schwartz MA, Assoian RK. Integrins and cell proliferation: regulation of cyclin-dependent kinases via cytoplasmic signaling pathways. J Cell Sci 2001; 114:2553-60; PMID:11683383
81. Bellucci R, De Propris MS, Buccisano F, Lisci A, Leone G, Tabilio A, de Fabritiis P. Modulation of VLA-4 and L-selectin expression on normal CD34+ cells during mobilization with G-CSF. Bone Marrow Transplant 1999; 23:1-8; PMID:10037043; http://dx.doi.org/10.1038/sj.bmt.1701522
82. Scott LM, Priestley GV, Papayannopoulou T. Deletion of alpha4 integrins from adult hematopoietic cells reveals roles in homeostasis, regeneration, and homing. Mol Cell Biol 2003; 23:9349-60; PMID:14645544; http://dx.doi.org/10. 1128/MCB.23.24.9349-9360.2003